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YEAR IN CARDIOLOGY SERIESMYEAR IN CARDIOLOGY SERIES779The Year in AtherothrombosisJavier Sanz, Valentin Fuster
Sanz and Fuster summarize important advances that took place during the last year in the
field of atherothrombotic disease. Papers were selected based on relevance, novelty, and
scientific quality. The review is divided into 4 distinct sections: epidemiology, mechanisms
of disease, early detection and risk stratification, and prevention and treatment.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
792edium-Term Outcomes Following Endovascular Treatment
of Common Femoral Artery StenosesRobert F. Bonvini, Aljoscha Rastan, Sebastian Sixt, Elias Noory, Thomas Schwarz, Ulrich Frank,
Marco Roffi, Pierre André Dorsaz, Uwe Schwarzwälder, Karlheinz Bürgelin, Roland Macharzina,
Thomas Zeller
Bonvini and colleagues reviewed a prospectively maintained single-center electronic database
of 360 consecutive percutaneous interventions of the common femoral artery (CFA). A total
of 27% were isolated CFA interventions, while 44% and 42% also involved inflow and
outflow vessels, respectively. Balloon angioplasty was performed as the primary intention in
virtually all cases, while stenting was needed for suboptimal angioplasty results in 37%. In-
hospital major (i.e., requiring surgery) and minor (i.e., treated percutaneously or
conservatively) complications occurred in 1.4% and 5.0% of procedures, respectively.
Restenosis 50% by duplex scanning and target lesion revascularization was observed in 28%
and 20% of the procedures, respectively. This large series suggests that the percutaneous
approach may be a valid alternative to surgery for CFA obstructions.
Editorial Comment: John R. Laird, p. 799(continued on page A-26)
AUGUST 16, 2011 (continued) A-26INTERVENTIONAL CARDIOLOGY801High Variability Between Hospitals in Rates of Obstructive CAD at AngiographyPamela S. Douglas, Manesh R. Patel, Steven R. Bailey, David Dai, Lisa Kaltenbach, Ralph G. Brindis,
John Messenger, Eric D. Peterson
Douglas and colleagues used data from the CathPCI Registry to determine hospital variability
in the rate of finding obstructive coronary artery disease (CAD) at elective coronary
angiography. This was a retrospective analysis of more than one-half million patients without
prior myocardial infarction or revascularization undergoing elective coronary angiography at
nearly 700 U.S. hospitals. The rates of obstructive coronary disease found at elective coronary
angiography varied from 23% to 100% and were consistent from year to year by hospital.
Hospitals with lower rates of obstructive CAD at angiography prescribed aspirin, beta-
blockers, platelet inhibitors, and statins less frequently. The rate of obstructive CAD found at
elective coronary angiography varied considerably among reporting centers and may represent
an opportunity for quality improvement.INTERVENTIONAL CARDIOLOGY810Similar Results in the BARI 2D Trial Regardless of AgeSheng-Chia Chung, Mark A. Hlatky, David Faxon, Kodangudi Ramanathan, Dale Adler,
Arshag Mooradian, Charanjit Rihal, Roslyn A. Stone, Joyce T. Bromberger, Sheryl F. Kelsey,
Maria Mori Brooks, and the BARI 2D Study Group
Chung and colleagues investigated the extent to which the effectiveness of cardiac and
diabetes treatment strategies for patients with coronary artery disease vary with age. In the
BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial,
2,368 patients with documented stable heart disease and type 2 diabetes were randomized to
receive prompt revascularization versus initial medical therapy and noninsulin- or insulin-
based therapy for diabetes. The effect of prompt revascularization versus medical therapy did
not differ by age for any of the health status outcomes. Similarly, there were no differences by
age in the effect of the randomized glycemia treatment strategy. The results of this analysis
confirm the broader lessons learned from the BARI 2D trial that revascularization and
medical therapy result in similar outcomes.CORONARY ARTERY DISEASE820Allopurinol Blocks Oxidative Stress, Improves Endothelial FunctionNarasimharajapura S. Rajendra, Sheila Ireland, Jacob George, Jill J. F. Belch, Chim C. Lang,
Allan D. Struthers
Allopurinol, a xanthine oxidase (XO) inhibitor, has recently been shown to prolong the time
to chest pain during exercise in patients with coronary artery disease (CAD). Rajendra and
colleagues investigated the effect of allopurinol on endothelial function. Allopurinol
significantly improved endothelium-dependent vasodilation, by both flow-mediated dilation
and forearm venous occlusion plethysmography. This effect was related to oxidative stress
(OS). This study demonstrates that in optimally treated CAD patients, high-dose allopurinol
profoundly reduces vascular OS and improves endothelial dysfunction.Editorial Comment: Peter H. Stone, p. 829
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MHEART RHYTHM DISORDERS831ECG Criteria May Distinguish ARVD/C From RVOT-VTKurt S. Hoffmayer, Orlando N. Machado, Gregory M. Marcus, Yanfei Yang, Colleen J. Johnson,
Simon Ermakov, Eric Vittinghoff, Ulhas Pandurangi, Hugh Calkins, David Cannom, Kathleen C. Gear,
Crystal Tichnell, Young Park, Wojciech Zareba, Frank I. Marcus, Melvin M. Scheinman
Hoffmayer and colleagues compared the electrocardiographic (ECG) morphology of
ventricular tachycardia (VT) or premature ventricular contractions with left bundle branch
block/inferior axis pattern to evaluate whether the ECG can distinguish patients with
arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from those with right
ventricular outflow tract-ventricular tachycardia (RVOT-VT). ARVD/C patients had a
significantly longer mean QRS duration in lead I, more often exhibited a precordial transition
in lead V6, and more often had at least 1 lead with notching. The most sensitive
haracteristic for the detection of ARVD/C was a QRS duration in lead I of 120 ms
sensitivity 88%, negative predictive value [NPV] 91%). QRS transition at V6 was most
pecific at 100% (positive predictive value 100%, NPV 77%). Several ECG criteria can help
istinguish right ventricular outflow tract arrhythmias originating from ARVD/C versus
VOT-VT patients.CARDIOMYOPATHY
839icrovascular Function Is Impaired in HCM Patients
With Sarcomere Myofilament Gene MutationsIacopo Olivotto, Francesca Girolami, Roberto Sciagrà, Michael J. Ackerman, Barbara Sotgia, J. Martijn Bos,
Stefano Nistri, Aurelio Sgalambro, Camilla Grifoni, Francesca Torricelli, Paolo G. Camici, Franco Cecchi
Olivotto and colleagues assessed myocardial blood flow (MBF) using positron emission
tomography in patients with hypertrophic cardiomyopathy (HCM). A total of 70% were
found to be genotype-positive with a known mutation. Compared with genotype-negative
patients, genotype-positive HCM patients had substantially lower MBF and also had more
myocardial fibrosis. These findings suggest a direct link between sarcomere gene mutations
and adverse remodeling of the microcirculation in HCM, accounting for the increased long-
term prevalence of ventricular dysfunction and heart failure in genotype-positive patients.(continued on page A-28)
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Filippo Cademartiri, Tracy Q. Callister, Hyuk-Jae Chang, Victor Cheng, Kavitha Chinnaiyan,
Benjamin J. W. Chow, Augustin Delago, Martin Hadamitzky, Joerg Hausleiter, Philipp Kaufmann,
Erica Maffei, Gilbert Raff, Leslee J. Shaw, Todd Villines, Daniel S. Berman, for the CONFIRM Investigators
Despite increasing adoption of coronary computed tomography angiography (CCTA) for
clinical use, there is limited “real-world” evidence to support the prognostic significance of
coronary artery disease (CAD) findings. Min and colleagues evaluated a cohort of 23,854
patients without known CAD undergoing CCTA between 2005 and 2009. Incident
mortality was associated with a dose-response relationship from nonobstructive CAD to
obstructive 1-, 2-, or 3-vessel CAD or left main CAD. The annualized rate of death in
patients without CAD by CCTA was low at 0.28%. CCTA was predictive of death in the
young and old and in men and women. This large study shows that the CCTA is a robust
predictor of the risk of mortality in patients without known CAD.Editorial Comment: Bernard De Bruyne, Carlos Van Mieghem, p. 861PULMONARY HYPERTENSION
863yncope Is a Marker of Poor Prognosis in Patients
With Pulmonary Arterial HypertensionRachel J. Le, Eric R. Fenstad, Hilal Maradit-Kremers, Robert B. McCully, Robert P. Frantz,
Michael D. McGoon, Garvan C. Kane
Le and colleagues investigated the prognostic significance of syncope at presentation in
patients with pulmonary arterial hypertension (PAH). A total of 12% of patients had a
history of syncope at the time of PAH diagnosis. There were no significant differences in sex,
age, functional class, 6-min walk distance, or etiology of PAH in syncopal versus nonsyncopal
patients. However, syncopal patients presented with worse right heart function and were at
double the risk of death during follow-up. Syncope in PAH is associated with a greater
degree of right heart dysfunction and is an independent predictor of a poor prognosis.(continued on page A-29)
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ECONGENITAL HEART DISEASE
868ubsequent Arch Reintervention After Balloon Aortoplasty
in Patients With a Norwood ProcedureDiego Porras, David W. Brown, Audrey C. Marshall, Pedro del Nido, Emile A. Bacha, Doff B. McElhinney
Patients born with hypoplastic left heart syndrome often require aortic arch reconstruction as
part of a Norwood procedure, which creates an anastomosis between the pulmonary and
systemic circulation. The reconstructed arch is at risk for developing stenoses, which are
initially treated with balloon dilation (BD). Porras and colleagues reviewed the records of
116 patients who had BD after a Norwood procedure to investigate why some patients
require multiple procedures for recurrent stenoses. The initial BD was acutely successful in
92% of patients, with a median gradient reduction from 26 to 3 mm Hg. Freedom from
reintervention was 69% at 1 year and 58% at 5 years. The risk of arch reintervention was
higher in patients with proximal obstruction, in those age 3 months at the time of BD, and
n those with a less successful acute result.ditorial Comment: John J. Lamberti, p. 877
